Depressive Episode Clinical Trial
Official title:
Cognitive Remediation Following Electroconvulsive Therapy in Patients With Treatment Resistant Depression: Randomized Controlled Trail of an Intervention for Relapse Prevention
Major depressive disorder (MDD) is worldwide one of the most prevalent and disabling mental health conditions. Electroconvulsive therapy (ECT) is a safe and effective treatment even though 6-month relapse rates are high. Cognitive side effects of ECT, such as reduced cognitive control, might trigger mechanisms that increase relapse in patients. As such, cognitive control training (CCT) holds promise as a non-pharmacological strategy to improve long-term effects of ECT (i.e., increase remission, and reduce depression relapse).
Eighty-eight participants aged between 18-70 years with major depressive disorder who start electroconvulsive treatment (ECT) will be included in this randomized controlled trial (RCT). Following (partial) response to ECT treatment (at least a 25% reduction of clinical symptoms), participants will be randomly assigned to a computer based CCT or active placebo control. A first aim of this RCT is to assess the effects of CCT compared to an active placebo condition on depression symptomatology, cognitive complaints, and quality of life. Secondly, participants will be monitored every two weeks for a period of six months following CCT/active placebo, allowing the detection of potential relapse of depression. Thirdly, the investigators will assess participant evaluation of the addition of cognitive remediation to ECT using qualitative interview methods (satisfaction, acceptability and appropriateness). Finally, in order to further advance the understanding of the mechanisms underlying effects of CCT, exploratory analyses may be conducted using facial video footage collected during the CCT/active control phase of the study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Completed |
NCT03449979 -
Single Session of tACS in a Depressive Episode
|
N/A | |
Recruiting |
NCT05708222 -
Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
|
||
Completed |
NCT01879111 -
Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback
|
N/A | |
Unknown status |
NCT01212848 -
Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation
|
Phase 3 | |
Not yet recruiting |
NCT05547711 -
Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting
|
N/A | |
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Completed |
NCT03288714 -
Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder
|
N/A | |
Completed |
NCT03899168 -
Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging
|
N/A | |
Terminated |
NCT03537547 -
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
|
Phase 4 | |
Recruiting |
NCT05910775 -
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
|
N/A | |
Completed |
NCT05683028 -
RCT for Electroconvulsive Treatment Followed by Cognitive Control Training
|
N/A | |
Enrolling by invitation |
NCT05701345 -
Study of Virtual Reality-based Medical Device for Patients With Depressive Disorder
|
N/A | |
Recruiting |
NCT04123301 -
Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics.
|
N/A | |
Completed |
NCT05686408 -
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
|
Phase 2 | |
Completed |
NCT03543410 -
A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression
|
Phase 2 | |
Completed |
NCT04953338 -
Mental Health Associations With Vitiligo
|
||
Recruiting |
NCT06152705 -
Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression
|
N/A | |
Completed |
NCT05462652 -
Self-guided Treatment for Adolescents Navigating Depression
|
N/A |